Alluvi Retatrutide 20mg

Alluvi Retatrutide 20mg offers a lower-dose option for research applications targeting GLP-1 and GIP receptors. This precision-formulated peptide comes in a 20mg pen containing 4 disposable 5mg doses with 12 needles and instruction materials. Perfect for dose titration and initial research protocols. Manufactured by Alluvi Healthcare with pharmaceutical-grade purity. Once-weekly administration protocol. Store in refrigerator (2°C to 8°C). For subcutaneous injection only. Each box includes Certificate of Analysis and detailed research documentation.